Mycobacteriology tests in Dubai & UAE

Compare available Mycobacteriology tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

Listed price range

600.00–4,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Mycobacteriology test prices

Showing 1–11 of 11 matching tests.

Mycobacteriology diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-870 AFB Culture & Anti-Tubercular DST Test This test evaluates the susceptibility of Mycobacterium tuberculosis to the anti-tubercular drug capreomycin.	Pure M. tuberculosis isolate	21 days from pure culture receipt	650.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Mycobacterium tuberculosis susceptibility to capreomycin"] Parameters [] Preparation ["No special patient preparation is required as the test uses a pre-grown pure culture isolate."] Indications ["Guidance for MDR-TB treatment modification", "Determining capreomycin resistance in Mycobacterium tuberculosis complex"] Measurement technique Confirm with laboratory Codes LOINC: 59367-1 ICD-10: A15.0, Z16.341, Z15.0 Clinical summary This test evaluates the susceptibility of Mycobacterium tuberculosis to the anti-tubercular drug capreomycin.
TEST-912 Culture-Based AFB Antitubercular Drug Susceptibility Testing (DST) Rapid 4-Drug Panel Test This test evaluates the susceptibility of cultured Mycobacterium tuberculosis complex to four key anti-TB drugs (Isoniazid, Rifampicin, Ethambutol, Pyrazinamide).	Pure culture of Mycobacterium tuberculosis complex	21 days from pure culture receipt	900.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Susceptibility to Isoniazid (INH)", "Susceptibility to Rifampicin (RIF)", "Susceptibility to Ethambutol (EMB)", "Susceptibility to Pyrazinamide (PZA)"] Parameters [{"name": "Isoniazid (INH)", "reference_range": "Susceptible / Resistant"}, {"name": "Rifampicin (RIF)", "reference_range": "Susceptible / Resistant"}, {"name": "Ethambutol (EMB)", "reference_range": "Susceptible / Resistant"}, {"name": "Pyrazinamide (PZA)", "reference_range": "Susceptible / Resistant"}] Preparation ["No patient preparation required for this test phase.", "A pure culture of Mycobacterium tuberculosis complex must be submitted."] Indications ["Diagnosis of tuberculosis", "Guidance for anti-tuberculosis treatment", "Detection of drug resistance", "Monitoring treatment response"] Measurement technique Confirm with laboratory Codes LOINC: 41683-7 ICD-10: Z01.89 Clinical summary This test evaluates the susceptibility of cultured Mycobacterium tuberculosis complex to four key anti-TB drugs (Isoniazid, Rifampicin, Ethambutol, Pyrazinamide).
TEST-886 Cultured AFB Anti‑Tubercular Drug Susceptibility Testing (DST) for Ofloxacin Test This diagnostic test evaluates the susceptibility of cultured Mycobacterium tuberculosis isolates to the antibiotic ofloxacin.	Pure Culture Isolate (Mycobacterium tuberculosis)	21 days from pure culture receipt	650.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Phenotypic susceptibility of Mycobacterium tuberculosis", "Resistance to ofloxacin"] Parameters [] Preparation [] Indications ["Diagnosis of MDR-TB or pre-XDR-TB", "Guiding treatment regimen selection for TB"] Measurement technique Confirm with laboratory Codes LOINC: 68545-1 ICD-10: Z11.1 Clinical summary This diagnostic test evaluates the susceptibility of cultured Mycobacterium tuberculosis isolates to the antibiotic ofloxacin.
TEST-862 Cultured AFB Antitubercular Drug Susceptibility Testing (DST) — Amikacin Test This test determines the minimum inhibitory concentration (MIC) of Amikacin against a pure culture of Mycobacterium tuberculosis complex.	Pure growth of Mycobacterium tuberculosis complex on solid or liquid media	21 days from receipt of pure culture isolate	600.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Minimum Inhibitory Concentration (MIC) of Amikacin", "Phenotypic susceptibility to Amikacin"] Parameters [{"name": "Amikacin Minimum Inhibitory Concentration (MIC)", "reference_range": "Susceptible (S), Intermediate (I), Resistant (R) based on established breakpoints"}] Preparation ["No direct patient preparation required as the test is performed on a cultured isolate."] Indications ["Guiding Category IV MDR-TB regimens", "Confirming Amikacin susceptibility before prolonged parenteral therapy", "Detecting all resistance mechanisms, including novel variants"] Measurement technique Confirm with laboratory Codes LOINC: 20454-0 ICD-10: Z16.21 Clinical summary This test determines the minimum inhibitory concentration (MIC) of Amikacin against a pure culture of Mycobacterium tuberculosis complex.
TEST-883 Cultured AFB Antitubercular DST Linezolid Test This test evaluates the susceptibility of Mycobacterium tuberculosis complex isolates to the antibiotic linezolid.	Pure culture isolate of Mycobacterium tuberculosis complex	21 days from receipt of pure culture isolate	700.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Minimum Inhibitory Concentration (MIC) of Linezolid", "Phenotypic drug susceptibility"] Parameters [{"name": "Minimum Inhibitory Concentration (MIC)", "reference_range": null}] Preparation ["Ensure a pure culture isolate is available", "Coordinate specimen collection timing if patient is on linezolid"] Indications ["Diagnosis of drug-resistant tuberculosis (MDR-TB, XDR-TB)", "Guidance for linezolid therapy selection", "Surveillance of antimicrobial resistance"] Measurement technique Confirm with laboratory Codes LOINC: 100342-9 ICD-10: A15.0, Z16.31 Clinical summary This test evaluates the susceptibility of Mycobacterium tuberculosis complex isolates to the antibiotic linezolid.
TEST-897 Cultured AFB Antitubercular DST Rapid 12-Drug Panel Test This test evaluates the susceptibility of cultured Mycobacterium tuberculosis complex isolates to 12 anti-tuberculosis drugs.	Isolated Mycobacterium tuberculosis complex culture	21 days from receipt of culture isolate	2,300.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Susceptibility to 12 anti-tuberculosis drugs", "Minimum Inhibitory Concentration (MIC)"] Parameters [{"name": "Bedaquiline", "reference_range": null}, {"name": "Linezolid", "reference_range": null}, {"name": "Clofazimine", "reference_range": null}, {"name": "Fluoroquinolones", "reference_range": null}, {"name": "Isoniazid", "reference_range": null}, {"name": "Rifampicin", "reference_range": null}, {"name": "Pyrazinamide", "reference_range": null}, {"name": "Ethambutol", "reference_range": null}, {"name": "Streptomycin", "reference_range": null}, {"name": "Amikacin", "reference_range": null}, {"name": "Moxifloxacin", "reference_range": null}, {"name": "Levofloxacin", "reference_range": null}] Preparation ["No special patient preparation is required.", "A pure culture isolate is needed."] Indications ["Diagnosis of drug-resistant tuberculosis", "Guidance for treatment selection in confirmed tuberculosis cases", "Monitoring treatment response"] Measurement technique Confirm with laboratory Codes LOINC: 52829-4 ICD-10: A15.0 Clinical summary This test evaluates the susceptibility of cultured Mycobacterium tuberculosis complex isolates to 12 anti-tuberculosis drugs.
TEST-902 Cultured AFB Antitubercular DST Rapid 16‑Drugs Panel Test This test evaluates the susceptibility of Mycobacterium tuberculosis isolates to 16 anti-TB drugs.	Mycobacterium tuberculosis complex culture isolate (pure growth)	21 days from pure culture submission	3,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Susceptibility to 16 anti-TB drugs", "Phenotypic drug resistance patterns"] Parameters [] Preparation ["No personal preparation is needed as the test is performed on a pre-grown culture."] Indications ["Diagnosis of drug-resistant tuberculosis (MDR/XDR-TB)", "Guidance for personalized anti-TB treatment regimens", "Monitoring treatment response in complex cases"] Measurement technique Confirm with laboratory Codes LOINC: 60535-9 ICD-10: A15.0 Clinical summary This test evaluates the susceptibility of Mycobacterium tuberculosis isolates to 16 anti-TB drugs.
TEST-923 Cultured AFB Antitubercular DST Rapid 19-Drug Panel Test This test evaluates the susceptibility of cultured Mycobacterium tuberculosis to 19 antitubercular drugs.	Cultured Mycobacterium tuberculosis isolate	21 calendar days	4,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Susceptibility to 19 antitubercular drugs", "Drug resistance profile"] Parameters [] Preparation [] Indications ["Diagnosis of drug-resistant tuberculosis", "Guidance for antitubercular therapy selection", "Surveillance of drug resistance patterns"] Measurement technique Confirm with laboratory Codes LOINC: 101468-0 ICD-10: Z01.89 Clinical summary This test evaluates the susceptibility of cultured Mycobacterium tuberculosis to 19 antitubercular drugs.
TEST-891 Cultured AFB Antitubercular DST Test This test evaluates the susceptibility of Mycobacterium tuberculosis isolates to the antibiotic moxifloxacin.	Pure Culture Isolate of Mycobacterium tuberculosis complex	21 days from receipt of pure culture isolate	800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Moxifloxacin susceptibility", "Mycobacterium tuberculosis resistance profile"] Parameters [] Preparation ["No patient preparation required; sample is a pure culture isolate."] Indications ["Diagnosis of MDR-TB", "Guidance for MDR-TB treatment regimens", "Monitoring treatment response"] Measurement technique Confirm with laboratory Codes LOINC: 94030-1 ICD-10: U84.0, A15.0 Clinical summary This test evaluates the susceptibility of Mycobacterium tuberculosis isolates to the antibiotic moxifloxacin.
TEST-919 Cultured AFB Drug Resistance (Anti‑Tubercular DST) Rapid 15‑Drug Panel Test This test evaluates the susceptibility of Mycobacterium tuberculosis isolates to 15 different anti-tubercular drugs.	Cultured Isolate (Mycobacterium tuberculosis complex) on solid/liquid media	21 days	2,700.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Susceptibility to 15 anti-tubercular agents", "Mycobacterium tuberculosis drug resistance profile"] Parameters [] Preparation [] Indications ["Diagnosis of drug-resistant tuberculosis (MDR-TB, XDR-TB)", "Guidance for personalized anti-tubercular therapy", "Monitoring treatment response in complex cases"] Measurement technique Confirm with laboratory Codes LOINC: 88122-7 ICD-10: A15.0, Z16.3 Clinical summary This test evaluates the susceptibility of Mycobacterium tuberculosis isolates to 15 different anti-tubercular drugs.
TEST-861 Cultured AFB Other Than Tuberculosis (MOTT) Drug Susceptibility Testing (DST) for Slow Growers Test This test evaluates the susceptibility of slow-growing nontuberculous mycobacteria (MOTT) to various antimycobacterial drugs using a broth microdilution method.	Pure culture isolate of slow-growing nontuberculous mycobacteria (MOTT)	14 Working Days from pure culture isolate submission	1,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Minimal Inhibitory Concentration (MIC) of antimycobacterial drugs", "Susceptibility of slow-growing MOTT isolates"] Parameters [] Preparation ["No special patient preparation is required for the culture isolate submission."] Indications ["Suspected infection with slow-growing nontuberculous mycobacteria (MOTT)", "Need to guide antibiotic therapy for MOTT infection", "Monitoring treatment response"] Measurement technique Confirm with laboratory Codes LOINC: 100337-6 ICD-10: A31.9, A31.0 Clinical summary This test evaluates the susceptibility of slow-growing nontuberculous mycobacteria (MOTT) to various antimycobacterial drugs using a broth microdilution method.

Category overview

Mycobacteriology: overview

The secure, accurate handling and deep diagnostic evaluation of Tuberculosis and severe atypical mycobacterial infections require a laboratory environment built on absolute precision and extreme biosafety. As an elite, highly specialized cornerstone of our diagnostic services, the Mycobacteriology department provides a rigorous, exhaustive evaluation of clinical samples using specialized Acid-Fast stains, advanced liquid culturing (MGIT), and ultra-sensitive molecular PCR within specialized negative-pressure suites. Utilizing state-of-the-art diagnostic technology, this expansive suite of testing isolates elusive respiratory pathogens and performs critical antimicrobial susceptibility profiling, providing the definitive data needed to safely guide your pulmonologist’s highly customized, prolonged antibiotic therapies and proactive public health interventions. Highly regarded for specialized diagnostic excellence across top diagnostic labs in Dubai and the UAE, DNA Labs ensures strict patient confidentiality, exceptional analytical precision, and incredibly dependable reporting. Secure the ultimate diagnostic confidence your respiratory health requires—schedule your mycobacteriology testing in UAE, coordinate a secure clinical sample transfer, or consult our expert microbiology professionals.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.